Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…
See Full ReportCountry Reports
Through interviews with the heads of some of India’s leading domestic pharmaceutical companies, this report delves into the biologics, biosimilars and new chemical entities being developed in India and taken abroad; the nation’s hubs of development and innovation, notably the northern state of Gujarat; and how Indian companies have stepped up their quality compliance game…
See Full Report
India can claim with some degree of force to be ‘the pharmacy to the world.’ Not only are Indian medicines consumed in the US and EU, but enterprising Indian companies are increasingly looking towards huge underserved developing markets across the globe. Furthermore, Indian companies are moving into the field of biologics; a handful of…
See Full Report
